Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Monsanto And Alnylam Join For Agriculture
by Michael McCoy
September 3, 2012
| A version of this story appeared in
Volume 90, Issue 36
Monsanto and Alnylam Pharmaceuticals have formed an alliance to advance biological crop protection products. Monsanto will pay Alnylam $29.2 million up front and could make future royalty payments. Monsanto says the pact is intended to bring Alnylam’s RNAi technology to BioDirect, its new effort in biopesticides. In a recent presentation, Monsanto Chief Technology Officer Robb Fraley said BioDirect involves the application of molecules that are in nature, such as RNA, to diminish the production of specific proteins in a target organism.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter